Modulation of Apoptosis by Cytotoxic Mediators and Cell-Survival Molecules in Sjögren's Syndrome

Hideki Nakamura1, Yoshiro Horai2, Toshimasa Shimizu3

  • 1Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki City, Nagasaki 852-8501, Japan. nhideki@nagasaki-u.ac.jp.

Insights

Sjögren's syndrome involves complex apoptotic pathways in exocrine glands. Epidermal growth factor (EGF) and toll-like receptors (TLRs) modulate these cell death processes, influencing inflammation and apoptosis.

Area of Science:

  • Immunology
  • Cell Biology
  • Pathogenesis of Autoimmune Diseases

Background:

  • Sjögren's syndrome (SS) pathogenesis involves genetic, cellular, and exocrine dysfunction factors.
  • Apoptosis, or programmed cell death, plays a critical role in the exocrine gland pathology of SS.

Purpose of the Study:

  • To elucidate the intricate mechanisms of apoptotic control within the exocrine glands of SS patients.
  • To investigate the roles of key molecular pathways, including Fas/Fas ligand, TRAIL, toll-like receptors (TLRs), and epidermal growth factor (EGF), in SS-related apoptosis.

Main Methods:

  • Review and discussion of pro- and anti-apoptotic signaling pathways.
  • Analysis of the Fas/Fas ligand system, including membrane-bound and soluble forms.
  • Investigation of tumor necrosis factor related apoptosis-inducing ligand (TRAIL)-mediated apoptosis via mitochondrial pathways.
  • Examination of toll-like receptor (TLR) involvement in inflammation and apoptosis of salivary gland epithelial cells (SGECs).
  • Assessment of epidermal growth factor (EGF) interactions with apoptotic pathways.

Main Results:

  • The Fas/Fas ligand system is implicated in apoptosis, though its soluble form's role is debated.
  • TRAIL induces apoptosis in SGECs through a mitochondrial pathway involving caspase 9.
  • TLRs (2-4, 7-9) are linked to inflammation, while TLR3 can induce SGEC apoptosis.
  • Epidermal growth factor (EGF) inhibits the Fas/FasL system and possesses dual actions on TLR3-induced inflammation and apoptosis.

Conclusions:

  • Apoptosis in SS exocrine glands is a tightly regulated process.
  • The balance between pro-apoptotic signals and growth factors like EGF is crucial in controlling SS pathogenesis.
  • Understanding these pathways offers potential therapeutic targets for Sjögren's syndrome.

Related Concept Videos

Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...